Abstract: Disclosed are computer-implemented quantitative stochastic model and simulation of cashflow dispersion forecasts influenced by fundamental evaluation of name specific risks for computing a metric indicative of risk versus return mapped to a quality score for an alternative asset.

Abstract: Provided herein are polymer materials that find use in, for example, delivery of short-chain fatty acids. In particular, polymers are provided that form stable nanoscale structures and release their payload, for example, by cleavage of a covalent bond (e.g., via hydrolysis or enzymatic cleavage). The polymers are useful, for example, for delivery of payloads (e.g., SCFAs) to the intestine for applications in health and treatment of disease, and have broad applicability in diseases linked to changes in the human microbiota including inflammatory, autoimmune, allergic, metabolic, and central nervous system diseases, among others.

Abstract: Methods and apparatus to detect commercial advertisements associated with media presentations are disclosed. An example method involves receiving a video frame and detecting a change in box-formatting between the video frame and a subsequent video frame. A transition between the video frame and the subsequent video frame is indicated as a commercial advertisement transition based on the detected change in box-formatting.

Abstract: A method according to certain embodiments generally involves operating a system including an unmanned aerial vehicle (UAV) and a base station. The base station includes a nest including an upper opening having an upper opening diameter and a lower opening having a lower opening diameter less than the upper opening diameter. The lower opening is accessible from within the base station. The method generally includes landing the UAV within the nest such that a portion of the UAV is accessible via the lower opening, releasably attaching a load to the UAV, and operating the UAV to deliver the load to a destination.

Abstract: Compositions and methods are described for a polymer hydrogel created by a cycloaddition reaction between an azide and an alkyne that proceeds rapidly without catalyst to produce the polymer hydrogel in less than ninety seconds. The polymer hydrogel can be used in in vivo applications for the localized delivery of therapeutic agent in aqueous solutions. An example of therapeutic delivery of a protein in a mouse model is demonstrated.

Abstract: Provided herein are polymer materials that find use in, for example, delivery of short-chain fatty acids. In particular, polymers are provided that form stable nanoscale structures and release their payload, for example, by cleavage of a covalent bond (e.g., via hydrolysis or enzymatic cleavage). The polymers are useful, for example, for delivery of payloads (e.g., SCFAs) to the intestine for applications in health and treatment of disease, and have broad applicability in diseases linked to changes in the human microbiota including inflammatory, autoimmune, allergic, metabolic, and central nervous system diseases, among others.

Abstract: An embodiment may involve web page metadata that defines a web page, first sub-page metadata that defines a first sub-page, and second sub-page metadata that defines a second sub-page, wherein the web page metadata includes specification of a viewport, and wherein the viewport is associated with an identifier. One or more processors may be configured to: receive a request for the web page; resolve the web page metadata into web content, wherein resolving the web page metadata includes: (i) determining, based on the identifier, a route associated with the viewport, (ii) determining, based on the route, a set of conditions associated with the viewport, (iii) determining that a particular condition is satisfied, wherein the particular condition is associated with the first sub-page and (iv) placing, based on the particular condition being satisfied, the first sub-page metadata in the viewport; and transmit the web content.

Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.

Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.

Abstract: Persistent storage may contain a plurality of user interface (UI) component definitions. One or more processors may be configured to: receive, by way of a platform UI builder, selection of a UI component definition from the plurality of UI component definitions; bind, by way of input entered into the platform UI builder, data to the UI component definition, wherein the data is from a data source, and wherein the input is a programmatic statement that references the data source or a set of values that references the data source; generate, by way of the platform UI builder, metadata representing the input; create, by a platform runtime, a UI component that incorporates the data into the UI component definition in accordance with the metadata; generate, by the platform runtime, a graphical user interface including the UI component; and provide, for display on a client device, a representation of the graphical user interface.

Abstract: Disclosed herein are features and improvements for a powered industrial vehicle, such as a forklift. In some embodiments, the forklift may have improved geometry and sensors. In some embodiments, the forklift may include an operator interface system for controlling powered industrial vehicles based on the field of view of an operator. In some embodiments, the forklift may include an integrated control system such that the operator cannot perform a certain operation without first performing a different, prior operation and/or such that the operator cannot perform two or more operations simultaneously which would result in unsafe operation. In some embodiments, a virtual reality simulator for the forklift may be provided.

Abstract: This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy and/or epileptic seizure disorders.

Abstract: Provided herein are polymer materials that find use in, for example, delivery of short-chain fatty acids. In particular, polymers are provided that form stable nanoscale structures and release their payload, for example, by cleavage of a covalent bond (e.g., via hydrolysis or enzymatic cleavage). The polymers are useful, for example, for delivery of payloads (e.g., SCFAs) to the intestine for applications in health and treatment of disease, and have broad applicability in diseases linked to changes in the human microbiota including inflammatory, autoimmune, allergic, metabolic, and central nervous system diseases, among others.

Abstract: Several embodiments of the present disclosure relate to therapeutic compositions configured to target the liver of a subject and that are useful in the treatment or prevention of one or more of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. In several embodiments, the compositions are configured for clearance of a circulating protein or peptide or antibody associated with one or more of the above-mentioned maladies. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.

Abstract: A cloud management system (180) only instructs a storage platform (100) in a private domain to implement an operation that reveals, modifies, or destroys data if an administrator (163) both provides valid credentials and is able to direct a services processing unit or SPU (120) in the private domain to send a message with valid contents and signature. An SPU (120) only performs operations that reveal, modify, or destroy data if signed instructions from the cloud management system (180) have originated or been relayed through a component (120) in the private domain. An attacker with access to the cloud management system (180) that does not also have access to a component (120) in the private domain is prevented from tampering with the storage platform (100).

Abstract: Several embodiments of the present disclosure relate to glycotargeting therapeutics that are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent. In several embodiments, the compositions are configured to target the liver and deliver antigens to which tolerance is desired. Methods and uses of the compositions for induction of immune tolerance are also disclosed herein.

Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.

Abstract: The various implementations described herein include a video camera assembly that includes: (1) a housing; (2) an image sensor positioned within the housing and having a field of view corresponding to a scene in the smart home environment; and (3) a concave-shaped front face positioned in front of the image sensor such that light from the scene passes through the front face prior to entering the image sensor; where the front face includes: (a) an inner section corresponding to the image sensor; and (b) an outer section between the housing and the inner section, the outer section having a concave shape that extends from an outer periphery of the outer section to an inner periphery of the outer section; and where the concave shape extends around an entirety of the outer periphery.

Abstract: Glycotargeting therapeutics are useful in the treatment of transplant rejection, autoimmune disease, food allergy, and immune response against a therapeutic agent.

Abstract: A method according to certain embodiments generally involves operating a system including an unmanned aerial vehicle (UAV) and a base station. The base station includes a nest including an upper opening having an upper opening diameter and a lower opening having a lower opening diameter less than the upper opening diameter. The lower opening is accessible from within the base station. The method generally includes landing the UAV within the nest such that a portion of the UAV is accessible via the lower opening, releasably attaching a load to the UAV, and operating the UAV to deliver the load to a destination.